Actively Recruiting
Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery
Led by University of California, Davis · Updated on 2025-05-15
215
Participants Needed
1
Research Sites
124 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a single site, prospective, non-blinded, non-randomized, before/after study. This study is designed to evaluate the impact of monitoring and reversal guidelines for neuromuscular blocking drugs on the post-operative outcomes for patients undergoing laparoscopic gastric bypass surgery.
CONDITIONS
Official Title
Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age greater than 18 years
- Scheduled for an elective laparoscopic gastric bypass procedure
You will not qualify if you...
- Age less than 18 years
- Pregnancy
- Prisoners
- Significant lung disease such as asthma or COPD requiring regular medication
- Need for supplemental oxygen before surgery to maintain hemoglobin saturation above 98%
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UC Davis Medical Center
Sacramento, California, United States, 95817
Actively Recruiting
Research Team
A
Ana P Arias, BS
CONTACT
J
Julio J Arana Pineda, BA
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here